Cargando…
Does combination therapy work in chronic thromboembolic pulmonary hypertension?
OBJECTIVE: The current experience with combination therapy in chronic thromboembolic pulmonary hypertension (CTEPH) is limited. We present the first survival results up to 5 years for dual combination therapy versus monotherapy in CTEPH. METHODS: All consecutive, non-operated CTEPH or residual PH af...
Autores principales: | van Thor, M.C.J., Snijder, R.J., Kelder, J.C., Mager, J.J., Post, M.C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270605/ https://www.ncbi.nlm.nih.gov/pubmed/32518816 http://dx.doi.org/10.1016/j.ijcha.2020.100544 |
Ejemplares similares
-
Long-term clinical value and outcome of riociguat in chronic thromboembolic pulmonary hypertension
por: van Thor, M.C.J., et al.
Publicado: (2019) -
Chronic thromboembolic pulmonary hypertension
por: Schölzel, B. E., et al.
Publicado: (2014) -
Safety of macitentan in sarcoidosis-associated pulmonary hypertension: a case-series
por: Mathijssen, H., et al.
Publicado: (2020) -
Safety and efficacy of balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension in the Netherlands
por: van Thor, M. C. J., et al.
Publicado: (2019) -
Quality of life in pulmonary arterial hypertension
por: Post, M.C., et al.
Publicado: (2015)